Tango Therapeutics, Inc.
TNGX
7 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 3 6:37 PM | Adam CrystalPresident, R&D | Sale | 27,000 | $22.87 | $617.6K | 115,743(D) | View → |
| May 1, 2026 | May 5 7:47 PM | Adam CrystalPresident, R&D | Sale | 27,000 | $21.23 | $573.1K | 115,743(D) | View → |
| Apr 15, 2026 | Apr 16 8:14 PM | Adam CrystalPresident, R&D | Sale | 38,460 | $25.00 | $961.5K | 112,622(D) | View → |
| Apr 1, 2026 | Apr 2 8:09 PM | Adam CrystalPresident, R&D | Sale | 27,000 | $21.20 | $572.5K | 112,622(D) | View → |
| Mar 25, 2026 | Mar 27 8:06 PM | Adam CrystalPresident, R&D | Sale | 12,000 | $20.11 | $241.3K | 112,622(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 3 6:37 PM | Adam CrystalPresident, R&D | Option Exercise | 27,000 | $5.20 | 341,040(D) | View → |
| May 1, 2026 | May 5 7:47 PM | Adam CrystalPresident, R&D | Option Exercise | 27,000 | $5.20 | 368,040(D) | View → |
| May 1, 2026 | May 5 7:46 PM | Matthew GallChief Financial Officer | Grant/Award | 240,000 | $20.98 | 240,000(D) | View → |
| Apr 29, 2026 | May 1 5:26 PM | Sung LeeDirector | Grant/Award | 5,200 | $22.06 | 5,200(D) | View → |
| Apr 15, 2026 | Apr 16 8:14 PM | Adam CrystalPresident, R&D | Option Exercise | 38,460 | $5.20 | 395,040(D) | View → |
| Apr 1, 2026 | Apr 2 8:09 PM | Adam CrystalPresident, R&D | Option Exercise | 27,000 | $5.20 | 433,500(D) | View → |
| Mar 25, 2026 | Mar 27 8:06 PM | Adam CrystalPresident, R&D | Option Exercise | 12,000 | $5.20 | 460,500(D) | View → |